Jeffrey S. Parkin

Array ( [id] => 220660 [patent_doc_number] => 07608273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Recombinant lentivirus encoding modified GP 120 signal sequences' [patent_app_type] => utility [patent_app_number] => 11/107364 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12081 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608273.pdf [firstpage_image] =>[orig_patent_app_number] => 11107364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131162 [patent_doc_number] => 07700273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor' [patent_app_type] => utility [patent_app_number] => 11/578122 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 19817 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700273.pdf [firstpage_image] =>[orig_patent_app_number] => 11578122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7217027 [patent_doc_number] => 20050260235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Aids vaccines' [patent_app_type] => utility [patent_app_number] => 11/096698 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12310 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260235.pdf [firstpage_image] =>[orig_patent_app_number] => 11096698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243819 [patent_doc_number] => 20050271678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Peptides derived from a retrovirus of the HIV group and their use' [patent_app_type] => utility [patent_app_number] => 11/084858 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9896 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271678.pdf [firstpage_image] =>[orig_patent_app_number] => 11084858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669375 [patent_doc_number] => 20080044435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Tat-Based Tolerogen Compositions and Methods of Making and Using Same' [patent_app_type] => utility [patent_app_number] => 10/598976 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11431 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044435.pdf [firstpage_image] =>[orig_patent_app_number] => 10598976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210034 [patent_doc_number] => 20070248618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Tat-Based vaccine Compositions and Methods of Making and Using Same' [patent_app_type] => utility [patent_app_number] => 10/598975 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9649 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248618.pdf [firstpage_image] =>[orig_patent_app_number] => 10598975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867436 [patent_doc_number] => 20080146495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Methods for Treating Hiv by Inhibiting Cd4 Down-Modulation' [patent_app_type] => utility [patent_app_number] => 11/908378 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26915 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146495.pdf [firstpage_image] =>[orig_patent_app_number] => 11908378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894906 [patent_doc_number] => 20060003445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Method and device for detecting feline immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 11/075958 [patent_app_country] => US [patent_app_date] => 2005-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6185 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003445.pdf [firstpage_image] =>[orig_patent_app_number] => 11075958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6944363 [patent_doc_number] => 20050196412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Non-pathogenic strains of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/035899 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 104 [patent_no_of_words] => 28562 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196412.pdf [firstpage_image] =>[orig_patent_app_number] => 11035899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135965 [patent_doc_number] => 20050180984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Modulating vaccine against HIV-1 Nef protein induced lymphocyte depletion' [patent_app_type] => utility [patent_app_number] => 11/030315 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7739 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180984.pdf [firstpage_image] =>[orig_patent_app_number] => 11030315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359537 [patent_doc_number] => 07485416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity' [patent_app_type] => utility [patent_app_number] => 11/022192 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 25 [patent_no_of_words] => 29790 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485416.pdf [firstpage_image] =>[orig_patent_app_number] => 11022192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996283 [patent_doc_number] => 20050136061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Anti-retroviral agents, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 11/018102 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5580 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136061.pdf [firstpage_image] =>[orig_patent_app_number] => 11018102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141283 [patent_doc_number] => 07691382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Antiviral polypeptides comprising tandem repeats of APOE 141-149 and variants thereof' [patent_app_type] => utility [patent_app_number] => 10/580761 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11612 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691382.pdf [firstpage_image] =>[orig_patent_app_number] => 10580761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705164 [patent_doc_number] => 20060194212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Treatment of AIDS' [patent_app_type] => utility [patent_app_number] => 11/007909 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41596 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194212.pdf [firstpage_image] =>[orig_patent_app_number] => 11007909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097675 [patent_doc_number] => 20050130134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment HIV-AIDS' [patent_app_type] => utility [patent_app_number] => 10/989692 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29242 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130134.pdf [firstpage_image] =>[orig_patent_app_number] => 10989692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807666 [patent_doc_number] => 20060094020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Methods and compositions for determining resistance or susceptibility of HIV-1 to stavudine' [patent_app_type] => utility [patent_app_number] => 10/976721 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15192 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094020.pdf [firstpage_image] =>[orig_patent_app_number] => 10976721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738077 [patent_doc_number] => 20060008467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Human immunodeficiency virus vaccine' [patent_app_type] => utility [patent_app_number] => 10/973977 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5776 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008467.pdf [firstpage_image] =>[orig_patent_app_number] => 10973977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938576 [patent_doc_number] => 20050112139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Immunogenic composition and method of developing a vaccine based on factor H binding sites' [patent_app_type] => utility [patent_app_number] => 10/971219 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21578 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112139.pdf [firstpage_image] =>[orig_patent_app_number] => 10971219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938580 [patent_doc_number] => 20050112143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Method of developing an immunogenic composition and HIV vaccine' [patent_app_type] => utility [patent_app_number] => 10/971445 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10838 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112143.pdf [firstpage_image] =>[orig_patent_app_number] => 10971445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216803 [patent_doc_number] => 07611712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide' [patent_app_type] => utility [patent_app_number] => 10/971229 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20896 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611712.pdf [firstpage_image] =>[orig_patent_app_number] => 10971229 [rel_patent_id] =>[rel_patent_doc_number] =>)